Insulin once a week, performed for diabetic patients

For diabetic patients, it could go from 365 to just 52 injections of insulin in a year. A real revolution in therapy seems to be near for the 500 million diabetic patients worldwide, over 3.5 million people in Italy. A new weekly basal insulin offers the same efficacy as existing daily insulins in patients with type 2 diabetes who have not used insulin before.

This is confirmed by two different studies published in Jama and in the New England Journal of Medicine. “This new molecule has the potential to simplify the therapy of diabetes that requires insulin therapy, eliminating the discomfort of daily injections for patients and thus increasing adherence to insulin therapy. A real epochal change and a marked improvement in patients’ quality of life diabetics,” he explains Roberto Trevisan, professor of Endocrinology at the University of Milano-Bicocca and director of Diabetology at the ASST Papa Giovanni XXIII of Bergamo, the only Italian researcher who participated in the final draft of the study in the New England Journal of Medicine. Trevisan reports that the approval of the new molecule by the regulatory bodies of the drug is now awaited in order to make it available.

Type 1 diabetes, the story of Jessica Zanardo: “The onset is the most difficult moment, for this I help those who get sick”

by Cinzia Lucchelli

April 15, 2023

The transition from daily to weekly intake represents a great advantage for type 2 diabetics, who are often elderly subjects, with multiple pathologies, and who must take different therapies on a daily basis. Another advantage of formulating the therapy on a weekly basis is the possibility of reducing the commitment required of healthcare professionals who deal with diabetics who require insulin, especially for those admitted to long-term residential healthcare facilities.

From diabetes to osteoporosis, the doctor prescribes the right sport for every disease

by Irma D’Aria

June 24, 2023